Durg maker Aurobindo Pharma has received the approval from the US Food and Drug Administration (USFDA) to manufacture and market Dexamethasone Sodium Phosphate Injection USP, 4 mg/mL (1 mL, 5 mL and 30 mL vials) in USA. The product is expected to be launched by the last quarter of the current fiscal.
- Dexamethasone Sodium Phosphate Injection can be used in the treatment of various conditions such as severe allergic reactions, arthritis, blood diseases, breathing problems, certain cancers, eye diseases, intestinal disorders and skin diseases.
Key Points:
- Aurobindo Pharma Headquarters: Hyderabad
No comments:
Post a Comment